BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37933911)

  • 1. Cell Therapy by Mesenchymal Stromal Cells Versus Myoblasts in a Pig Model of Urinary Incontinence.
    Knoll J; Amend B; Harland N; Isser S; Bézière N; Kraushaar U; Stenzl A; Aicher WK
    Tissue Eng Part A; 2024 Jan; 30(1-2):14-30. PubMed ID: 37933911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precise injection of human mesenchymal stromal cells in the urethral sphincter complex of Göttingen minipigs without unspecific bulking effects.
    Amend B; Kelp A; Vaegler M; Klünder M; Frajs V; Klein G; Sievert KD; Sawodny O; Stenzl A; Aicher WK
    Neurourol Urodyn; 2017 Sep; 36(7):1723-1733. PubMed ID: 27935100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and precise delivery of cells in the urethral sphincter complex by a novel needle-free waterjet technology.
    Linzenbold W; Jäger L; Stoll H; Abruzzese T; Harland N; Bézière N; Fech A; Enderle M; Amend B; Stenzl A; Aicher WK
    BJU Int; 2021 Apr; 127(4):463-472. PubMed ID: 32940408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term structural and functional effects of autologous muscle precursor cell therapy in a nonhuman primate model of urinary sphincter deficiency.
    Badra S; Andersson KE; Dean A; Mourad S; Williams JK
    J Urol; 2013 Nov; 190(5):1938-45. PubMed ID: 23618586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Therapy for Stress Urinary Incontinence.
    Hart ML; Izeta A; Herrera-Imbroda B; Amend B; Brinchmann JE
    Tissue Eng Part B Rev; 2015 Aug; 21(4):365-76. PubMed ID: 25789845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic Analysis of Human Mesenchymal Stem Cell Therapy in Incontinent Rat Injured Urethra.
    Sadeghi Z; Kenyon JD; Richardson B; Khalifa AO; Cartwright M; Conroy B; Caplan A; Cameron MJ; Hijaz A
    Tissue Eng Part A; 2020 Jul; 26(13-14):792-810. PubMed ID: 32614683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smooth Muscle Progenitor Cells Derived From Human Pluripotent Stem Cells Induce Histologic Changes in Injured Urethral Sphincter.
    Li Y; Wen Y; Wang Z; Wei Y; Wani P; Green M; Swaminathan G; Ramamurthi A; Pera RR; Chen B
    Stem Cells Transl Med; 2016 Dec; 5(12):1719-1729. PubMed ID: 27460854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological and Urodynamic Effects of Autologous Stromal Vascular Fraction Extracted from Fat Tissue with Minimal Ex Vivo Manipulation in a Porcine Model of Intrinsic Sphincter Deficiency.
    Boissier R; Magalon J; Sabatier F; Veran J; Giraudo L; Giusiano S; Garcia S; Dignat-George F; Arnaud L; Magalon G; Lechevallier E; Berdah S; Karsenty G
    J Urol; 2016 Sep; 196(3):934-42. PubMed ID: 27265221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell versus Chemokine Therapy in a Nonhuman Primate Model of Chronic Intrinsic Urinary Sphincter Deficiency.
    Williams JK; Dean A; Badra S; Lankford S; Poppante K; Badlani G; Andersson KE
    J Urol; 2016 Dec; 196(6):1809-1815. PubMed ID: 27267321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regeneration of degenerated urinary sphincter muscles: improved stem cell-based therapies and novel imaging technologies.
    Amend B; Vaegler M; Fuchs K; Mannheim JG; Will S; Kramer U; Hart ML; Feitz W; Chapple C; Stenzl A; Aicher WK
    Cell Transplant; 2015; 24(11):2171-83. PubMed ID: 25608017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Functional Comparison of Treatment of Intrinsic Sphincter Deficiency with Muscle-Derived and Adipose Tissue-Derived Stem Cells.
    Cui L; Meng Q; Wen J; Gao Z; Yan Z; Tian Y; Xu P; He X; Yu H; Lian P
    IUBMB Life; 2018 Oct; 70(10):976-984. PubMed ID: 30212601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human amniotic fluid stem cell injection therapy for urethral sphincter regeneration in an animal model.
    Kim BS; Chun SY; Lee JK; Lim HJ; Bae JS; Chung HY; Atala A; Soker S; Yoo JJ; Kwon TG
    BMC Med; 2012 Aug; 10():94. PubMed ID: 22906045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smooth Muscle Precursor Cells Derived from Human Pluripotent Stem Cells for Treatment of Stress Urinary Incontinence.
    Wang Z; Wen Y; Li YH; Wei Y; Green M; Wani P; Zhang P; Pera RR; Chen B
    Stem Cells Dev; 2016 Mar; 25(6):453-61. PubMed ID: 26785911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small activating RNA induces myogenic differentiation of rat adipose-derived stem cells by upregulating MyoD.
    Wang C; Chen Z; Wu J; Zhang Y; Hu J; Ge Q; Yang W; Xu H; Liu J; Ye Z
    Int Braz J Urol; 2015; 41(4):764-72. PubMed ID: 26401871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing and monitoring of urethral sphincter deficiency in a large animal model.
    Kelp A; Albrecht A; Amend B; Klünder M; Rapp P; Sawodny O; Stenzl A; Aicher WK
    World J Urol; 2017 Dec; 35(12):1977-1986. PubMed ID: 28940030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell applications in regenerative medicine for stress urinary incontinence: A review of effectiveness based on clinical trials.
    Barakat B; Franke K; Schakaki S; Hijazi S; Hasselhof V; Vögeli TA
    Arab J Urol; 2020 Apr; 18(3):194-205. PubMed ID: 33029431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle precursor cells for the restoration of irreversibly damaged sphincter function.
    Eberli D; Aboushwareb T; Soker S; Yoo JJ; Atala A
    Cell Transplant; 2012; 21(9):2089-98. PubMed ID: 22236637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCT.
    Constable L; Abrams P; Cooper D; Kilonzo M; Cotterill N; Harding C; Drake MJ; Pardoe MN; McDonald A; Smith R; Norrie J; McCormack K; Ramsay C; Uren A; Mundy T; Glazener C; MacLennan G
    Health Technol Assess; 2022 Aug; 26(36):1-152. PubMed ID: 35972773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model.
    Zhao W; Zhang C; Jin C; Zhang Z; Kong D; Xu W; Xiu Y
    Eur Urol; 2011 Jan; 59(1):155-63. PubMed ID: 21050657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress urinary incontinence animal models as a tool to study cell-based regenerative therapies targeting the urethral sphincter.
    Herrera-Imbroda B; Lara MF; Izeta A; Sievert KD; Hart ML
    Adv Drug Deliv Rev; 2015 Mar; 82-83():106-16. PubMed ID: 25453264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.